A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. [electronic resource]
Producer: 20180910Description: 2539-2548 p. digitalISSN:- 1421-9778
- Antineoplastic Combined Chemotherapy Protocols
- Area Under Curve
- Cyclophosphamide -- administration & dosage
- Databases, Genetic
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Middle Aged
- Neoadjuvant Therapy
- Paclitaxel -- administration & dosage
- RNA, Long Noncoding -- genetics
- RNA, Messenger -- metabolism
- ROC Curve
- Remission Induction
- Transcriptome
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.